Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | - | 5.0 |
Min SIP Amount | ₹500 | ₹500 |
Expense Ratio | 2.32 | 1.57 |
NAV | ₹14.18 | ₹448.09 |
Fund Started | 13 Mar 2023 | 07 May 2007 |
Fund Size | ₹297.86 Cr | ₹30419.61 Cr |
Exit Load | - | - |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | -4.54% | 3.85% |
3 Year | - | 23.47% |
5 Year | - | 25.54% |
1 Year
3 Year
5 Year
Equity | 98.11% | 93.55% |
Cash | 0.09% | 6.32% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Polycab India Ltd. | 5.24% |
HDFC Asset Management Company Ltd. | 5.10% |
Metropolis Healthcare Ltd. | 4.82% |
Muthoot Finance Ltd. | 4.79% |
Dr. Lal Pathlabs Ltd. | 4.66% |
Coromandel International Ltd. | 4.20% |
Gillette India Ltd. | 4.14% |
Alkem Laboratories Ltd. | 4.12% |
Marico Ltd. | 3.96% |
Mphasis Ltd. | 3.93% |
Name | Assets |
|---|---|
HDFC Bank Ltd. | 8.94% |
Reliance Industries Ltd. | 5.06% |
Tata Steel Ltd. | 3.44% |
ICICI Bank Ltd. | 3.29% |
Cipla Ltd. | 3.01% |
Mahindra & Mahindra Ltd. | 2.83% |
ITC Ltd. | 2.83% |
State Bank of India | 2.68% |
Axis Bank Ltd. | 2.41% |
Kotak Mahindra Bank Ltd. | 2.39% |
Name | Dhaval Patel | Dinesh Balachandran |
Start Date | 08 Mar 2023 | 01 Dec 2024 |
Name
Start Date
Description | The Scheme seeks to generate income and long-term capital appreciation from a diversified portfolio of predominantly equity and equity-related instruments. | The scheme seeks capital appreciation through investments in equities, cumulative convertible preference shares and fully convertible debentures and bonds. The scheme was converted into an open-ended plan in November 1999. |
Launch Date | 13 Mar 2023 | 07 May 2007 |
Description
Launch Date